[Tumor marker--personal experience. Mass survey and outpatients screening of pancreatic cancer].
To investigate the possibility that to detect carcinoma of the pancreas at an early stage by mass survey or outpatients screening, we performed the multicentral study for pancreatic cancer in Japan for two years from 1984 to 1985, using serum CA 19-9 and elastase-1 determinations or ultrasonography. Only 4 cases of pancreatic cancer were found out by mass survey, and according to outpatients screening with gastrointestinal complaints or jaundice, 85 patients were found to have pancreatic cancer. These results suggest that mass screening of persons without symptom is not worthy of the early detection of pancreatic cancer, however, outpatients screening gis useful for detecting curative cancers of the pancreas.
Homma
T
T
Shinshu University School of Medicine, Cardiovascular Institute, Matsumoto, Japan.
D000553:Ambulatory Care; D000951:Antigens, Neoplasm / Q000032:analysis; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000032:analysis; D014408:Biomarkers, Tumor / Q000032:analysis*; D006801:Humans; D008403:Mass Screening; D010044:Outpatient Clinics, Hospital; D010196:Pancreatic Elastase / Q000032:analysis; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging / Q000517:prevention & control*; D014463:Ultrasonography
D000951:Antigens, Neoplasm; D015295:Antigens, Tumor-Associated, Carbohydrate; D014408:Biomarkers, Tumor; C031192:oncofetal antigens; D010196:Pancreatic Elastase